Akira Shimane

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Takahiro Sawada, Hideo Tsubata, Naoko Hashimoto et al. · Cardiovascular Diabetology · 2016 · 101 citations · Full text

Medicine, Cardiology, Endocrinology +17

Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy

Misato Chimura, Tetsuari Onishi, Yasue Tsukishiro et al. · Heart · 2016 · 70 citations

Medicine, Radiology, Biomedical Imaging +13

Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

Takahiro Sawada, Kenzo Uzu, Naoko Hashimoto et al. · Journal of Atherosclerosis and Thrombosis · 2019 · 44 citations · Full text

Medicine, Cardiology, Pharmacology +17

Distribution of Ventricular Fibrosis Associated With Life‐Threatening Ventricular Tachyarrhythmias in Patients With Nonischemic Dilated Cardiomyopathy

Misato Chimura, Kunihiko Kiuchi, Katsunori Okajima et al. · Journal of Cardiovascular Electrophysiology · 2015 · 39 citations

Medicine, Cardiology, Internal Medicine +15